Ezra's Notes Checked November 16, 2026
Investor Holdings

By @ezracrangle

← David Einhorn, latest 13F

Gain Therapeutics

In David Einhorn's portfolio · Greenlight Capital

Ticker GANX

Still in the portfolio as of Q3 2026. Every quarter it shows up in a Greenlight Capital 13F, newest first.

QuarterActivitySharesWeightPriceValue
Q3 2026 No change 566,130 0.0% $1.73 $979K
Q2 2026 No change 566,130 0.0% $2.03 $1.1M
Q1 2026 No change 566,130 0.0% $1.94 $1.1M
Q4 2025 No change 566,130 0.1% $3.22 $1.8M
Q3 2025 No change 566,130 0.0% $1.77 $1.0M
Q2 2025 No change 566,130 0.0% $1.80 $1.0M
Q1 2025 No change 566,130 0.1% $1.91 $1.1M
Q4 2024 No change 566,130 0.1% $2.16 $1.2M
Q3 2024 No change 566,130 0.0% $1.78 $1.0M
Q2 2024 No change 566,130 0.0% $1.28 $725K
Q1 2024 Reduce 4% 566,130 0.1% $3.77 $2.1M
Q4 2023 No change 588,410 0.1% $3.26 $1.9M
Q3 2023 Add 8% 588,410 0.1% $3.28 $1.9M
Q2 2023 No change 546,560 0.1% $4.48 $2.4M
Q1 2023 No change 546,560 0.1% $4.82 $2.6M
Q4 2022 No change 546,560 0.1% $3.13 $1.7M
Q3 2022 No change 546,560 0.1% $3.26 $1.8M
Q2 2022 No change 546,560 0.2% $3.60 $2.0M
Q1 2022 No change 546,560 0.1% $4.09 $2.2M
Q4 2021 No change 546,560 0.2% $5.43 $3.0M
Q3 2021 No change 546,560 0.3% $7.44 $4.1M
Q2 2021 No change 546,560 0.3% $10.00 $5.5M
Q1 2021 Buy 546,560 0.6% $14.92 $8.2M

Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.